AA
48
-12
JPM
69
2
WY
54
4
LEG
36
4
CF
57
-2
GT
62
6
LLY
37
-3
NSC
60
3
HRB
57
5
PM
62
-2
MCHP
41
4
XYL
49
4
SYK
64
-4
MCD
52
2
HCP
66
8
RSG
71
3
LB
63
22
HST
49
-9
SE
61
-4
ORLY
62
2
AA
48
-12
JPM
69
2
WY
54
4
LEG
36
4
CF
57
-2
GT
62
6
LLY
37
-3
NSC
60
3
HRB
57
5
PM
62
-2
MCHP
41
4
XYL
49
4
SYK
64
-4
MCD
52
2
HCP
66
8
RSG
71
3
LB
63
22
HST
49
-9
SE
61
-4
ORLY
62
2
Financhill
Back

Cartesian Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
40

RNAC
Cartesian Therapeutics

Last Price:
18.99
Seasonality Move:
13.13%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
244.97
Seasonality Move:
11.66%
Sell
40
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $18.87. The Score for RNAC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $244.89. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $18.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $244.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 49.49 Sell
Chaikin Money Flow: 56766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.74 - 21.66) Sell
Bollinger Bands (100): (14.35 - 20.33) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.65 Sell
Relative Strength Index (14 RSI): 37.82 Sell
Chaikin Money Flow: -229766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (250.02 - 288.16) Sell
Bollinger Bands (100): (248.72 - 281.72) Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.5 Buy
20-day SMA: 19.15 Sell
50-day SMA: 19.39 Sell
200-day SMA: 19.98 Sell
8-day EMA: 17.91 Buy
20-day EMA: 18.75 Buy
50-day EMA: 18.93 Sell
200-day EMA: 20.95 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 245.62 Sell
20-day SMA: 263.27 Sell
50-day SMA: 272.49 Sell
200-day SMA: 211.63 Buy
8-day EMA: 248.36 Sell
20-day EMA: 259.36 Sell
50-day EMA: 265.3 Sell
200-day EMA: 231.03 Buy

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):